Drug Testing Locations - North Attleboro, MA

Drug Testing in North Attleboro, MA

North Attleboro, Massachusetts Statistics

North Attleboro, located in Bristol County, reported a 15% increase in drug overdose deaths between 2019 and 2020.

In 2021, Bristol County, which includes North Attleboro, registered over 1,200 emergency calls related to drug incidents.

A survey in North Attleboro indicated that 12% of high school students had used marijuana in the past month.

North Attleboro's Bristol County saw a 20% rise in admissions to drug treatment facilities in 2020.

Bristol County's needle exchange programs, including those in North Attleboro, have distributed over 500,000 syringes as of 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in North Attleboro, MA & Drug Testing Policies

North Attleboro businesses adhere to stringent drug-free workplace policies. Various employers in the area, influenced by state guidelines, advocate for pre-employment and random drug screenings to ensure a safe work environment. Employers endeavor to safeguard productivity and safety by implementing these measures.

The Massachusetts Workplace Safety and Health Programs provide resources to assist local businesses in formulating effective drug testing policies. Consistent adherence helps companies in North Attleboro maintain workplace integrity.

Government Efforts with Drug Problems in North Attleboro, MA

The Town of North Attleboro collaborates closely with the Massachusetts Department of Public Health to tackle drug abuse. The primary goal is to reduce overdose rates and provide educational programs targeted at young residents. By integrating local resources, they strive to address the peculiar drug-related challenges faced by the community.

Additionally, the Executive Office of Health and Human Services plays a significant role in supporting North Attleboro's drug prevention efforts. Grant funding from the state helps implement various community initiatives designed to increase public awareness and offer comprehensive rehabilitation options.

Local Drug Busts & News in North Attleboro, MA

North Attleboro law enforcement has been active in conducting drug busts to cleanse the community of illicit substances. In a notable operation, the Bristol County Task Force apprehended several drug traffickers in 2022, seizing substantial amounts of opioids and other illegal drugs.

In addition, public events aimed at raising awareness of the perils of drug misuse are regularly organized. These engage the community and aim to foster a collaborative response against drug-related issues, thereby reinforcing the town's resilience against drug trafficking and abuse.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in North Attleboro, MA. Trusted by employers nationwide for accurate results and exceptional service.

Massachusetts DOT/Non DOT Physicals

Massachusetts Vision Tests

Massachusetts Audiograms

Massachusetts Respirator Fit Tests

Massachusetts Lift Tests

Massachusetts Background Checks

Clinical Testing Services

TB Testing in MA

Diabetes Testing in MA

Infectious Disease Testing in MA

Sickle Cell Anemia Testing in MA

Women/Men's Health Testing in MA

Resources & Citations

Road to Recovery

MA Health Care

The PROJECT

McLean Hospital

Learn to Cope

Hope House

Colonial Health Group

Stanley Street Treatment and Resources

Bureau of Substance Addiction Services

High Point Treatment Center

Drug Testing Near North Attleboro, MA

South Walpole, MA

Highland Lake, MA

Rehoboth, MA

Franklin Town, MA

Foxborough, MA

Norton Center, MA

Mansfield, MA

Norton, MA

Mansfield Center, MA

Wrentham, MA

North Seekonk, MA

Attleboro, MA

Plainville, MA

North Attleborough Center, MA

North Attleborough, MA

Frequently Asked Questions

Customer Reviews